Tus kws kho mob
QP47-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2019